I understand, I dont have much time for managing these many businesses as well in my portfolio…To be honest I always had that FOMO of seeing the posts which goes like if you had invested Rs.10000, it would have gone 10x or 20x. I have to let go of few scripts then and reconstruct, stock picking and portfolio building are 2 different art then.
Okay let this be a start of a new journey then, making a mistake, reconstructing and travelling all along.
Specially views on Likely impact of US FDA approval of karTX developed by Neuland labs for BRISTOL MYERS SQIB. Since Bristol Myer is planning to supply by October end to patients and Neuland likely to start production of karTX immediately.
Any views on current price movement in Neuland Labs . It will help if someone can share any potential triggers . Thanks
Rajeesh ji, I know you have a solid research, but I would stress on the fact that you can choose which 15 or so you would want or have a stronger conviction than the others , because after a while the transcripts, annual reports, analyzing the business models and comparing its peers of 30+ companies is laboriously tough.
As Charlie munger says -” The idea of diversification makes sense to a point – if you don’t know what you’re doing. If you want the standard result and don’t want to end up embarrassed – then of course, you should widely diversify. But nobody is entitled to a lot of money for holding this view.”
In the below tracker, I have started tracking important company goals for S Chand. These goals are referred to as ‘monitorables’ in the tracker.I will update this document regularly to reflect the current status of these goals.
Here’s a snapshot of what the tracker includes:
I hope this information makes it easier to observe how well companies are progressing towards their stated goals.
Screenshot of the tracker below:
Full tracker attached below:
Tracking Company Monitorables-11.xlsx (158.1 KB)
| Company | Allocation | Thesis |
|---|---|---|
| Infosys | 11.01 | Largecap IT with high cashflows. Excellent track record with consitent dividend & Buybacks |
| HCL Tech | 10.59 | Largecap IT with better track record than many of its peers. Consistent dividends as well as growth in teens. |
| Bajaj Finance | 10.10 | Consistent performer which got de-rated significantly which made entry possible. |
| Mahindra & Mahindra | 6.75 | Dominant launches. Absolute star performer in SUV segment. |
| Natco Pharma | 6.14 | Unique business model with strong balance sheet. Company is diversifying in other areas and markerts. |
| Sharda Cropchem | 6.14 | Agrochem recovery play. Asset light model with debt free balance sheet. |
| Power Grid | 5.78 | Monopoly in power distribution + attractive dividend yield + reasonable growth |
| KNR Construction | 5.56 | One of better managed companies in one of toughest sectors. Sectoral tailwinds and lower valuations as well as proven track record. |
| Axis Bank | 5.37 | Private bank with attractive valuations and growth. |
| Shriram Piston | 5.19 | Strong Auto Ancillary company with consistent performance. |
| PI Industries | 5.04 | Consistent performer which finally gave valuation comfort for entry. |
| Kotak Mahindra Bank | 4.79 | Consistent performer available at reasonable price. Has long runway for growth. Strong subsidiaries. |
| Nirlon | 4.54 | Rental real estate play with good dividend yield. |
| Ganesh Housing Corporation | 4.45 | Deleveraged Real estate company operating in huge growth market. Huge Landbank and rental income in upcoming IT SEZ provides cashflow visibility. |
| Narayana Hrudayalaya | 4.31 | Healthcare provider with good track record and long runway for growth |
| PSP Projects | 4.24 | Excellent execution record. Valuation comfort because of recent headwinds. |
Another order win
Sarda Energy do have iron ore block in Gadchiroli District, it’s a joint venture between Shyam metalics and Sarda Energy